Literature DB >> 29600045

Validation of the T descriptor in the new 8th TNM classification for non-small cell lung cancer.

Hee Suk Jung1, Jin Gu Lee2, Chang Young Lee2, Dae Joon Kim2, Kyung Young Chung2.   

Abstract

BACKGROUND: To validate new proposals for the revision of T descriptors and to compare the prognostic value of the seventh and forthcoming eighth edition of the tumor, node and metastasis (TNM) classification for lung cancer.
METHODS: A retrospective analysis was conducted of 1,316 patients with non-small lung cancer who underwent pulmonary resection between 1999 and 2012. Patients who had a positive nodal status or distant metastasis were excluded. We classified these patients according to the seventh and eighth edition of the TNM system, and analyzed differences in stage specific survival. Harrell's concordance (C)-index and Heagerty's integrated area under the curve (iAUC) were used to assess the overall predictive ability of the different TNM versions.
RESULTS: There were no significant survival differences between each stage based on the T stage criteria of the eighth edition, most notably between T1a and T1b (P=0.752), and T1c, T2a, and T2b (P=0.832). The C-indices of the classification based on the seventh and eighth edition were 0.681 and 0.675, respectively. There was no significant difference in the C-indices between the seventh and eighth edition. The iAUC value for overall survival of the seventh and eighth staging editions was 0.637 and 0.631, respectively. The differences in iAUC between the seventh and eighth editions were also not statistically significant.
CONCLUSIONS: The newly proposed T descriptors in the eighth TNM classification system did not allow a more accurate prediction of prognosis compared with the current seventh edition in our population.

Entities:  

Keywords:  Lung neoplasms; neoplasm staging; prognosis

Year:  2018        PMID: 29600045      PMCID: PMC5863126          DOI: 10.21037/jtd.2017.12.20

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  9 in total

1.  Survival model predictive accuracy and ROC curves.

Authors:  Patrick J Heagerty; Yingye Zheng
Journal:  Biometrics       Date:  2005-03       Impact factor: 2.571

2.  Evaluation of the new TNM staging system proposed by the International Association for the Study of Lung Cancer at a single institution.

Authors:  Kotaro Kameyama; Mamoru Takahashi; Keiji Ohata; Hitoshi Igai; Akihiko Yamashina; Tomoaki Matsuoka; Tatsuo Nakagawa; Norihito Okumura
Journal:  J Thorac Cardiovasc Surg       Date:  2009-03-09       Impact factor: 5.209

Review 3.  Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors.

Authors:  F E Harrell; K L Lee; D B Mark
Journal:  Stat Med       Date:  1996-02-28       Impact factor: 2.373

4.  The IASLC lung cancer staging project: the new database to inform the eighth edition of the TNM classification of lung cancer.

Authors:  Ramón Rami-Porta; Vanessa Bolejack; Dorothy J Giroux; Kari Chansky; John Crowley; Hisao Asamura; Peter Goldstraw
Journal:  J Thorac Oncol       Date:  2014-11       Impact factor: 15.609

5.  The IASLC Lung Cancer Staging Project: Proposals for the Revisions of the T Descriptors in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer.

Authors:  Ramón Rami-Porta; Vanessa Bolejack; John Crowley; David Ball; Jhingook Kim; Gustavo Lyons; Thomas Rice; Kenji Suzuki; Charles F Thomas; William D Travis; Yi-Long Wu
Journal:  J Thorac Oncol       Date:  2015-07       Impact factor: 15.609

6.  The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours.

Authors:  Peter Goldstraw; John Crowley; Kari Chansky; Dorothy J Giroux; Patti A Groome; Ramon Rami-Porta; Pieter E Postmus; Valerie Rusch; Leslie Sobin
Journal:  J Thorac Oncol       Date:  2007-08       Impact factor: 15.609

Review 7.  TNM classification for lung cancer.

Authors:  Yoh Watanabe
Journal:  Ann Thorac Cardiovasc Surg       Date:  2003-12       Impact factor: 1.520

8.  Prognostic evaluation based on a new TNM staging system proposed by the International Association for the Study of Lung Cancer for resected non-small cell lung cancers.

Authors:  Takayuki Fukui; Shoichi Mori; Shunzo Hatooka; Masayuki Shinoda; Tetsuya Mitsudomi
Journal:  J Thorac Cardiovasc Surg       Date:  2008-08-15       Impact factor: 5.209

9.  The IASLC Lung Cancer Staging Project: proposals for the revision of the T descriptors in the forthcoming (seventh) edition of the TNM classification for lung cancer.

Authors:  Ramón Rami-Porta; David Ball; John Crowley; Dorothy J Giroux; James Jett; William D Travis; Masahiro Tsuboi; Eric Vallières; Peter Goldstraw
Journal:  J Thorac Oncol       Date:  2007-07       Impact factor: 15.609

  9 in total
  4 in total

1.  New TNM staging in lung cancer (8th edition) and future perspectives.

Authors:  José-María Matilla; M Zabaleta; E Martínez-Téllez; J Abal; A Rodríguez-Fuster; J Hernández-Hernández
Journal:  J Clin Transl Res       Date:  2020-09-02

Review 2.  Validation of the 8th lung cancer TNM classification and clinical staging system in a German cohort of surgically resected patients.

Authors:  Samantha Taber; Joachim Pfannschmidt
Journal:  Innov Surg Sci       Date:  2020-08-12

3.  8th Edition Tumor, Node, and Metastasis T-Stage Prognosis Discrepancies: Solid Component Diameter Predicts Prognosis Better than Invasive Component Diameter.

Authors:  Kazuhito Funai; Akikazu Kawase; Kiyomichi Mizuno; Sin Koyama; Norihiko Shiiya
Journal:  Cancers (Basel)       Date:  2020-06-15       Impact factor: 6.639

4.  Clinical significance of part-solid lung cancer in the eighth edition TNM staging system.

Authors:  Tatsuro Okamoto; Michiyo Miyawaki; Gouji Toyokawa; Takashi Karashima; Miyuki Abe; Yohei Takumi; Takafumi Hashimoto; Atsuhi Osoegawa; Tetsuzo Tagawa; Hideya Takeuchi; Mototsugu Shimokawa; Kenji Sugio
Journal:  Interact Cardiovasc Thorac Surg       Date:  2022-01-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.